|
pA2
online
© Copyright 2003 The British Pharmacological Society
|
059P
University of Surrey
Summer Meeting June 2003
|
Morphine
withdrawal in A2A adenosine receptor
knockout mice
A.Bailey, H. M. B. Lesscher, M. D. W. Kelly, L. Davis, C. Leden1,
S. M. O. Hourani & I. Kitchen. School of Biomedical and Life
Sciences, University of Surrey, Guildford, GU2 7XH. 1
Institut de Recherche Interdisciplinaire en Biologie Humaine et
Nucleaire, Universite Libre de Bruxelles, Belgium.
|

Print abstract
Search PubMed
for:
Bailey
A
Lesscher
HMB
Kelly
MDW
Davis
C
Ledent
C
Hourani
SMO
Kitchen
I
|
Much evidence
supports the hypothesis that A2A
receptors play an important role in the expression of morphine withdrawal
and that the dopaminergic system might be involved (Zarrindast et al.,
1999). We have evaluated morphine withdrawal signs in wild-type and A2A
receptor knockout mice generated by Ledent's group (Ledent et al.,
1997). To investigate further if µ opioid receptor expression and
G-protein activation are altered in the absence of the A2A
receptor gene under conditions of morphine withdrawal, quantitative autoradiography
of µ opioid receptors and µ opioid receptor-stimulated guanylyl
5'-[ -[35S]thio]-triphosphate
([35S]GTP S)
autoradiography were carried out in brain sections of morphine-withdrawn
wild-type and A2A
receptor knockout mice. Moreover, to investigate whether D2
dopamine receptor expression is altered in withdrawn A2A
receptor knockout mice, quantitative autoradiography of D2
dopamine receptors was carried out in brain sections of morphine-withdrawn
wild-type and mutant mice.
Wild type and A2A
receptor knockout mice (8-10 week old) were treated for 7 days with morphine
sulphate (24 mg/kg/day), administered subcutaneously via osmotic minipumps.
Seven days after the pumps were implanted, naloxone HCl (10 mg/kg, i.p)
was injected in order to precipitate opioid withdrawal. Both objective
(weight loss, urine and faecal matter, number of jumps, number of wet
dog shakes, number of face washes, number of paw tremors, number of writhes)
and subjective measures (diarrhoea score, ptosis score) of withdrawal
behaviour were scored for a period of 30 minutes according to a measurement
protocol described by Kitchen et al. (1993).
Following behavioural assessment, mice were killed and adjacent coronal
brain sections were cut from morphine-withdrawn wild-type and A2A
receptor knockout mice for the determination of total and non-specific
binding of [3H]D-Ala2-MePhe4-Gly-ol5
enkephalin (DAMGO) (4 nM) and [3H]raclopride (4 nM) to µ opioid
and D2 dopamine receptors respectively.
DAMGO (3 µM) stimulated [35S]GTP S
(0.04 nM) autoradiography was also carried out in brain sections of withdrawn
wild-type and mutant mice. The autoradiographic procedures were performed
as detailed previously (Kitchen et al., 1997; Kirschke et al.,
2002).
A significant enhancement in the number of jumps (+/+: 3.3±1.9;
-/- 45.3 ±19.0, P<0.01, n=9-12), paw tremors (+/+: 95.3 ±15.7;
-/-: 327.7 ±101.6, P<0.01, n=9-12) and writhes (+/+: 19.9 ±7.5;
-/-: 46.7 ±13.1, P<0.05, n=9-12) was observed in morphine-withdrawn
A2A receptor knockout mice compared to wild-type. No significant changes
in D2 and µ receptor binding (P>0.05)
were observed in any of the brain regions analysed. However, a significant
increase in the % level of µ receptor-stimulated [35S]GTP S
binding (+/+: 27.7 ± 8.0%; -/-: 71.5 ± 11.9%, P<0.05,
n=4) was observed in the nucleus accumbens of withdrawn knockout mice.
The data indicate
that adenosine, via its action on A2A
receptors, can control the expression of opioid withdrawal and that inhibition
of µ receptor G-protein activation is involved in the adenosinergic
control of morphine withdrawal.
Kirschke, C. et al(2002) Eur J Pharmacol 446, 43-51.
Kitchen, I. et al (1993) Neurotoxicol 14, 125-130.
Kitchen, I. et al(1997) Brain Res 778, 73-88.
Ledent, C. et al(1997) Nature 388, 674-678.
Zarrindast, M.R. et al (1999) Eur J Pharmacol 369,
17-22.
|